Body
A new study by Best Practices LLC contains performance metrics from which pharmaceutical companies can perform gap analyses to assess manufacturing performance and identify improvement opportunities. “Pharmaceutical Manufacturing: Cost, Staffing & Utilization Metrics,” contains the following findings:
- Capacity utilization is a key driver in cost management and production efficiency. Those facilities getting the most out of their equipment tend to perform better in solid dose and injectables productions.
- Too much variety in product types can lead to under-used equipment, and diluted management, maintenance and quality focus. For many companies, focusing on one type of manufacturing process, or a limited line of products, yields significant efficiency, economy of scale and a fine-tuned operation.
- Most manufacturers reported only average degrees of automation in their facilities. One company with a high degree of automation reported considerably better maintenance cost, headcount and overtime performance—compared to that of other benchmark partners.
“A solid understanding of manufacturing costs among world-class companies is the first step in evaluating a company’s own current practices,” says Chris Bogan, Best Practices LLC CEO. “This report is the only tool of its kind that can help executives at manufacturing plants identify critical performance gaps and create a specific path for marked process improvement.”
For more information, visit www.best-in-class.com.
Add new comment